Vetsys Pharmaceutical
High-purity therapeutic agents, customized animal wellness compound formulas, and robust industrial processing systems optimized for international markets.
Founded in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) has built a strong status as an industry leader in the animal pharmaceutical and biochemical additive sectors. Backed by a registered capital of 30 million RMB, Vetsys operates a GMP-certified manufacturing complex designed to meet the strict demands of global bio-security standards.
Our manufacturing lines feature specialized production units for powders, premixes, sterile injections, powder injections, high-yield oral solutions, solid tablets, therapeutic granules, herbal drug extracts, and modern sanitizing disinfectants. By scaling up advanced production technologies, Vetsys crossed annual sales of 20 million USD in the domestic market by 2015, and has since expanded its global network.
Vetsys separates itself from traditional chemical suppliers by investing heavily in technological research and development. Our independent biological research institute features five specialized laboratories equipped with HPLC, gas chromatography, and molecular weight distribution analyzers. Supported by a team of senior scientists and enzymology researchers, Vetsys quickly develops customized biochemical solutions to match the changing demands of the international market.
Our ongoing commitment to biological innovation ensures Vetsys stays ahead of industry shifts, offering clients the technical documentation, formulation stability, and process support needed to secure a competitive edge.
The global market for enzyme supplements is growing rapidly, driven by the complete ban on antibiotic growth promoters (AGPs) in livestock feed across major agricultural markets. Industrial-scale animal feed producers now rely on biocatalysts to maintain optimal feed conversion ratios (FCR). Enzymes like phytases, proteases, xylanases, and beta-glucanases are essential for breaking down anti-nutritional factors in plant-based feed, supporting gut integrity, and improving nutrient absorption.
Vetsys combines advanced chemical synthesis with custom hardware fabrication, ensuring our packaging systems, dosing equipment, and manufacturing tooling meet strict global tolerances.
Vetsys offers complete, end-to-end B2B solutions designed for regional distributors, agricultural integrations, and feed manufacturers. We look beyond standard catalog sales, engineering tailored biochemical systems and process setups that fit directly into our clients' existing lines.
Quality is the foundation of our work at Vetsys. We monitor every stage of production through our strict quality management system. From testing raw materials to inspecting finished products, each batch undergoes complete analytical validation to ensure it meets international quality standards.
Importing biochemical additives and active pharmaceutical ingredients (APIs) requires navigating complex regulatory frameworks. Vetsys supports international clients by providing complete documentation and technical registration files.
Our dedicated regulatory affairs team prepares complete registration dossiers, certificates of analysis (COA) checked by HPLC, material safety data sheets (MSDS), and origin certificates. Whether you are complying with EU feed regulations, US FDA guidelines, or local customs frameworks in Southeast Asia and Latin America, Vetsys ensures smooth market clearance.
As industrial farming moves toward precision agriculture, Vetsys is expanding its biotechnological capabilities to meet the next generation of animal nutrition needs. Our R&D roadmap focuses on improving thermal stability, target-specific enzyme release, and sustainable production processes.
We are scaling production of lipid-coated and silica-matrix encapsulated enzymes. This technology protects active enzymes from the high heat of feed pelleting and ensures controlled release within the animal's digestive tract.
We are developing combined probiotics and enzymes (synbiotics) that work together to balance gut microflora, limit pathogen colonization, and reduce reliance on synthetic therapies.
By upgrading to energy-recovery fermentation loops and bio-based raw feedstocks, we aim to transition our entire enzyme extraction pipeline to carbon-neutral operations.
Clear, technical answers to common questions from global sourcing managers, feed nutritionists, and regulatory directors.
Select from our range of therapeutic solutions, plant-based nutritional extracts, and high-performance processing systems.